The company
Gain Therapeutics, Inc.
GANX · Nasdaq
GANX stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 31 weeks. It is 31.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 31
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 47 (+9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 1,923,546$3.9M | +153,758+8.7% |
| Potomac Capital Management, Inc.reduced · filed 14 Aug 2026 | 946,400$1.9M | -62,200−6.2% |
| JONES FINANCIAL COMPANIES LLLPreduced · filed 14 Aug 2026 | 608,592$1.1M | -23,023−3.6% |
| DME Capital Management, LPunchanged · filed 14 Aug 2026 | 566,130$1.1M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 480,269$975K | +80,383+20.1% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 453,501$921K | +6,159+1.4% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 274,957$558K | +49,911+22.2% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 231,534$470K | +1,555+0.7% |
| UBS Group AGreduced · filed 13 Aug 2026 | 215,012$436K | -5,477−2.5% |
| Stratos Wealth Partners, LTD.added · filed 11 Aug 2026 | 200,000$406K | +68,379+52.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.